Advancements in personalized medicine have the potential to significantly reduce the incidence and severity of acute toxicity. By tailoring treatments based on a patientâs genetic profile, healthcare providers can choose therapies that are more effective and less toxic. Pharmacogenomics is one such field that studies how genes affect a person's response to drugs, enabling more precise dosing and reduced side effects.
